mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.04 |
mRNA |
AMG-706 |
FIMM |
pan-cancer |
AAC |
0.33 |
0.05 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.05 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.05 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.05 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.05 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.05 |
mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.05 |
mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.05 |
mRNA |
UNC0638 |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.05 |